Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Lee Jackson | Jan 7, 2020 at 7:20 AM EST

RBC Capital Markets Out With First Top Picks Equity List for 2020

These five top picks from the RBC all make sense for growth investors looking to move to companies with more…

Chris Lange | Dec 26, 2019 at 8:40 AM EST

Major Biotechs See Rising Short Interest

The December 13 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Dec 13, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle,…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Nov 27, 2019 at 8:40 AM EST

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data…

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

Lee Jackson | Nov 6, 2019 at 7:00 AM EST

Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential

These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite…

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Lee Jackson | Oct 11, 2019 at 7:10 AM EDT

5 Raymond James Analyst Favorite Picks With Huge Implied Upside

These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid…

Chris Lange | Oct 10, 2019 at 10:00 AM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

1 … 10 11 12 13 14 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

RBC Capital Markets Out With First Top Picks Equity List for 2020

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential

Major Biotechs See Rising Tide in Short Interest

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

5 Raymond James Analyst Favorite Picks With Huge Implied Upside

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Gilead Sciences : GILD

All Gilead Sciences Articles

RBC Capital Markets Out With First Top Picks Equity List for 2020

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential

Major Biotechs See Rising Tide in Short Interest

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

5 Raymond James Analyst Favorite Picks With Huge Implied Upside

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Featured Reads

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients